DOCSLIB.ORG

ESRR16 Final Programme 1.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ESRR16 Final Programme 1.Pdf Downloaded from orbit.dtu.dk on: Oct 05, 2021 Development of an experimental method using Cs-131 to evaluate radiobiological effects of internalized Auger-electron emitters. Fredericia, Pil; Severin, Gregory; Groesser, Torsten; Köster, Ulli; Jensen, Mikael Published in: 18th European Symposium on Radiopharmacy and Radiopharmaceuticals Publication date: 2016 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Fredericia, P., Severin, G., Groesser, T., Köster, U., & Jensen, M. (2016). Development of an experimental method using Cs-131 to evaluate radiobiological effects of internalized Auger-electron emitters. In 18th European Symposium on Radiopharmacy and Radiopharmaceuticals: Final programme (pp. 114-114). [PP52] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. 18th European Symposium on Radiopharmacy and Radiopharmaceuticals FINAL PROGRAMME April 07-10, 2016 Salzburg, Austria 18th European Symposium on Radiopharmacy and Radiopharmaceuticals April 07-10, 2016 Salzburg, Austria TABLE OF CONTENTS Welcome Address ...................................................................................................................................... 3 Scientific Committee ................................................................................................................................. 4 Local Organising Committee ..................................................................................................................... 4 Organising Secretariat ............................................................................................................................... 4 Congress Venue .......................................................................................................................................... 4 Exhibitors & Sponsors ................................................................................................................................ 5 General Information (A-Z) .......................................................................................................................... 6 Programme Overview ................................................................................................................................. 9 Highlights ................................................................................................................................................. 10 Invited Lectures .................................................................................................................................. 10 Scientific Programme ............................................................................................................................... 10 Thursday, April 07, 2016 ...................................................................................................................... 10 Friday, April 08, 2016 ........................................................................................................................... 11 Saturday, April 09, 2016 ...................................................................................................................... 12 Sunday, April 10, 2016 ......................................................................................................................... 13 Venue Overview ...................................................................................................................................... 15 *Cover pictures from Tourismus Salzburg Page 2 18th European Symposium on Radiopharmacy and Radiopharmaceuticals April 07-10, 2016 Salzburg, Austria WELCOME ADDRESS Dear colleagues, It is our great pleasure to welcome you to the 18th Symposium on Radiopharmacy and Radio- pharmaceuticals in Salzburg, Austria, located in equal distance from the major Austrian Universities Graz, Innsbruck and Vienna. The symposium is jointly organized by the Austrian community of Pharmacists and Chemists being involved in Radiopharmacy, Medicinal Radiochemistry and Radiopharmaceutical Research also representing different aspects of our field from CNS applications to therapeutic radio- pharmaceuticals, 11C and 18F-chemistry to radiometals as well as from research and development to daily radiopharmacy practice. Salzburg is a small city with a long cultural history, being strongly connected with Mozart, the “Sound of Music” and the annual Music Festival. The famous Fortress, the baroque Cathedral and church makes it a UNESCO World Heritage Site, its attractions being most famous in the world. The Symposium Venue is right in the centre of Salzburg and allows you to stay at the same location with your colleagues for discussion and exchange. It is in walking distance to all important sights of the city, the train station and the local airport. Excellent train connections to Munich and Vienna airport allow you to reach our symposium easily from all over the world. Besides an interesting scientific programme we will also surprise you with some nice social events giving you a flavour of Austrian history, culture and food. We invite you to come to Salzburg for this new edition of ESRR in 2016 and are really looking forward to welcome you. Clemens Decristoforo Herbert Kvaternik Markus Mitterhauser Wolfgang Wadsak Page 3 18th European Symposium on Radiopharmacy and Radiopharmaceuticals April 07-10, 2016 Salzburg, Austria SCIENTIFIC COMMITTEE Martin Behe Switzerland Petra Kolenc-Peitl Slovenia Valentina Ferrari United Kingdom Antony Gee United Kingdom LOCAL ORGANISING COMMITTEE Clemens Decristoforo Medical University Innsbruck, Austria Herbert Kvaternik Medical University Graz, Austria Markus Mitterhauser Medical University Vienna, Austria Wolfgang Wadsak Medical University Vienna, Austria ORGANISING SECRETARIAT EANM Executive Secretariat Andreas Felser Petra Neubauer Schmalzhofgasse 26 1060 Vienna, AUSTRIA Tel.: +43-(0) 890 44 27 Fax: +43-(0)890 44 27 - 9 Email: [email protected] URL: www.esrr.info CONGRESS VENUE Wyndham Grand Salzburg Conference Center Fanny-von-Lehnert-Str. 7 5020 Salzburg Salzburg (Austria) Tel.: +43 (0)662 4688-0 URL: http://www.wyndhamgrandsalzburg.com/ The ESRR is organized in cooperation with the International Atomic Energy Agency Page 4 18th European Symposium on Radiopharmacy and Radiopharmaceuticals April 07-10, 2016 Salzburg, Austria EXHIBITORS & SPONSORS We would like to thank all exhibitors and sponsor of the ESRR 2016 for their support! ABX advanced biochemical compounds Biomedizinische Forschungsreagenzien GmbH Bayer Healthcare DSD Pharma Eckert & Ziegler Europe GmbH Elysia Germany GmbH GE Healthcare IASON GmbH IBA SA (ION BEAM APPLICATION) IRE ELIT ITG Isotope Technologies Garching GmbH jiangsu Huayi Technology Co, Ltd. Ridgeview Instruments AB Rotem GmbH Scintomics GmbH Siemens Healthcare GmbH Trasis SA Von Gahlen Nederland B.V. Page 5 18th European Symposium on Radiopharmacy and Radiopharmaceuticals April 07-10, 2016 Salzburg, Austria GENERAL INFORMATION (A-Z) Airport & Arrival Information The airport of Salzburg is located about four kilometers from the city center. It takes 15 minutes to reach the historic city center by taxi or public bus. Salzburg Airport is the arrival airport for many international airlines and low-cost carriers. Direct flights to Salzburg are available from Berlin, Düsseldorf, Hannover, Hamburg, Cologne/Bonn, Frankfurt, Leipzig-Halle, Amsterdam, Vienna, London, Manchester, Stockholm, Zurich and other cities.A convenient airport shuttle also takes passengers from Munich Airport to Salzburg. Salzburg Train Station is a 15 minutes' walk from the historic city center. Here you can transfer to a trolley bus, regional bus, local train or suburban train. As a border station to Germany, Salzburg has outstanding Eurocity, Intercity and ICE connections. Salzburg's new suburban railroad connects the city with the surrounding towns. Salzburg is at the hub of the European highway network: the A1 Vienna-Salzburg, the A8 Munich– Salzburg and the A10 Villach–Salzburg converge in Salzburg. Please remember to purchase a toll sticker if you are driving to Salzburg. Certificate of Attendance Upon arrival all registered delegates will receive a certificate of attendance. Climate The daytime temperatures in April linger between 4° - 14° Celsius. Credit cards All major credit cards, including Eurocard, Diners, VISA and Mastercard are accepted in restaurants, hotels, shopping centers and stores. Travel cheques can be cashed in most banks and exchange offices. Currency The official currency in Austria is EUR (€). You can exchange your currency without any limits for total amount at all banks and exchange offices in Vienna. When exchanging your currency, you will need your passport or official ID-card. If you do not have it with you, the bank may refuse to exchange your currency
Load more

Recommended publications
  • 6-[18 F] Fluoro-L-DOPA: a Well-Established Neurotracer with Expanding Application Spectrum and Strongly Improved Radiosyntheses
    Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 674063, 12 pages http://dx.doi.org/10.1155/2014/674063 Review Article 6-[18F]Fluoro-L-DOPA: A Well-Established Neurotracer with Expanding Application Spectrum and Strongly Improved Radiosyntheses M. Pretze,1 C. Wängler,2 and B. Wängler1 1 Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany 2 Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, 68167 Mannheim, Germany Correspondence should be addressed to B. Wangler;¨ [email protected] Received 26 February 2014; Revised 17 April 2014; Accepted 18 April 2014; Published 28 May 2014 Academic Editor: Olaf Prante Copyright © 2014 M. Pretze et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 18 For many years, the main application of [ F]F-DOPA has been the PET imaging of neuropsychiatric diseases, movement disorders, and brain malignancies. Recent findings however point to very favorable results of this tracer for the imaging of other malignant diseases such as neuroendocrine tumors, pheochromocytoma, and pancreatic adenocarcinoma expanding its application spectrum. With the application of this tracer in neuroendocrine tumor imaging, improved radiosyntheses have been developed. Among these, 18 the no-carrier-added nucleophilic introduction of fluorine-18, especially, has gained increasing attention as it gives [ F]F-DOPA in higher specific activities and shorter reaction times by less intricate synthesis protocols.
    [Show full text]
  • Meeting Report (Pdf)
    Nanosized Delivery of Radiopharmaceuticals 2nd Research Coordination Meeting of the CRP 5–9 October 2015 Padua, Italy (May (May 13) 1 4 - C FOREWORD The currently used therapeutic agents in nuclear medicine continue to pose medical challenges mainly due to the limited uptake of radiocompound within tumour sites. This limited accumulation accounts for the fact that current beta-emitting therapeutic nuclear medicine agents have failed to deliver optimum therapeutic payloads at tumour sites. Actually, no other radiolabelled therapeutic agent has been capable to get close to the remarkably high target accumulation that was demonstrated by the long-lasting radionuclide I-131 in thyroid cancer. This means that metastases of several different types of aggressive cancers cannot be controlled, making it difficult to treat cancer patients. Therefore, new delivery modalities that result in (i) effective delivery of therapeutic probes with optimum payloads, site specifically at the tumour sites, minimal/tolerable systemic toxicity, and (ii) higher tumour retention, would bring about a clinically measurable shift in the way cancers are diagnosed and treated. Nanotechnology has the potential to bring about this paradigm shift in the early detection and therapy of various forms of human cancers because radioactive nanoparticles of optimum sizes for penetration across tumour cell membranes can be engineered through a myriad of interdisciplinary approaches, involving teams of experts from nuclear medicine, materials sciences, physics, chemistry, tumour biology and oncologists. Therefore, the overall approach which encompasses application of nanoparticulate radioactive probes in combination with polymeric nanomaterials has a realistic potential to generate the next generation of tumour specific theranostic nanoradiopharmaceuticals and minimize/eliminate delivery and tumour accumulation problems associated with the existing traditional nuclear medicine agents.
    [Show full text]
  • Final Program
    1 General Information SCOPE OF THE CONFERENCE The 12th Joint MMM/Intermag Conference is sponsored jointly by the American Institute of Physics (through Physics Conferences Incorporated) and the Magnetics Society of IEEE. The Conference will be held at the Hyatt Regency Chicago in the heart of Chicago, Illinois, easily accessible from O'Hare and Midway Airports. Members of the international scientific and engineering communities interested in recent developments in funda- mental and applied magnetism are invited to attend the Conference and con- tribute to its technical sessions. Sessions will include invited and contributed papers in oral and poster sessions, invited symposia, a plenary session, and two evening sessions, one of which will be in a tutorial format. The Confer- ence provides an outstanding opportunity for participants to meet their col- leagues and discuss the latest advances in magnetism. Please note that all of the conference details, including web links for registration and hotel reser- vations, are available at the conference website: http://www.magnetism.org CHICAGO Few cities in the world can match the character and culture of Chicago. Here you can find world-class dining, museums and entertainment. Chicago is the largest and most visited city in the Midwest of the United States. The Chicago Convention & Tourism Bureau is dedicated to helping you enjoy your stay in Chicago. On its web site, http://www.choosechicago.com you can experience the city like a local by obtaining the latest information on Chicago attractions such as the Navy Pier and Millennium Park, as well as the numerous outstanding museums and galleries.
    [Show full text]
  • Optimisation of Synthesis, Purification and Reformulation of (R)-[N-Methyl-11C]PK11195 for in Vivo PET Imaging Studies
    Optimisation of Synthesis, Purification and Reformulation of (R)-[N-methyl-11C]PK11195 for In Vivo PET Imaging Studies Vítor Hugo Pereira Alves Integrated Master in Biomedical Engineering Physics Department Faculty of Sciences and Technology of University of Coimbra 2012 To my Parents, Optimisation of Synthesis, Purification and Reformulation of (R)-[N-methyl-11C]PK11195 for In Vivo PET Imaging Studies Vítor Hugo Pereira Alves Supervisor: Miguel de Sá e Sousa Castelo Branco Co-supervisor: Antero José Pena Afonso de Abrunhosa Dissertation presented to the Faculty of Sciences and Technology of the University of Coimbra to obtain a Master’s degree in Biomedical Engineering Physics Department Faculty of Sciences and Technology of University of Coimbra 2012 This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognize that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without proper acknowledgement. i Acknowledgments First of all, I would like to express my gratitude to Professor Antero Abrunhosa, for the opportunity given to carry out this work, for all the knowledge and for the full confidence. More than a project supervisor, he was a friend and excellent professor for his support and encouragement to reach the defined goals. To Professor Miguel Castelo-Branco, director of the Institute for Nuclear Sciences Applied to Health and also supervisor of this work for all support and interest in this project. To Professor Francisco Alves, I am grateful for his full availability to help, and for all the times that I asked for carbon-11.
    [Show full text]
  • Automation of the Radiosynthesis of Six Different 18F-Labeled Radiotracers on the Allinone Shihong Li, Alexander Schmitz, Hsiaoju Lee and Robert H
    Li et al. EJNMMI Radiopharmacy and Chemistry (2016) 1:15 EJNMMI Radiopharmacy DOI 10.1186/s41181-016-0018-0 and Chemistry RESEARCH Open Access Automation of the Radiosynthesis of Six Different 18F-labeled radiotracers on the AllinOne Shihong Li, Alexander Schmitz, Hsiaoju Lee and Robert H. Mach* * Correspondence: [email protected] Abstract Department of Radiology, University of Pennsylvania, Philadelphia, PA, Background: Fast implementation of positron emission tomography (PET) into clinical USA and preclinical studies highly demands automated synthesis for the preparation of PET radiopharmaceuticals in a safe and reproducible manner. The aim of this study was to develop automated synthesis methods for these six 18F-labeled radiopharmaceuticals produced on a routine basis at the University of Pennsylvania using the AllinOne synthesis module. Results: The development of automated syntheses with varying complexity was accomplished including HPLC purification, SPE procedures and final formulation with sterile filtration. The six radiopharmaceuticals were obtained in high yield and high specific activity with full automation on the AllinOne synthesis module under current good manufacturing practice (cGMP) guidelines. Conclusion: The study demonstrates the versatility of this synthesis module for the preparation of a wide variety of 18F-labeled radiopharmaceuticals for PET imaging studies. Keywords: PET, Radiotracer, Automation, AllinOne, HPLC, SPE, ISO-1, FTP, FTT, F-Gln Background Positron emission tomography (PET) facilities have recently been growing exponen- tially as PET is an especially sensitive molecular imaging technique quantitatively measuring tracers in nano- to picomolar range in comparison with other modalities like magnetic resonance imaging (MRI) or computerized tomography (CT). The main limitation of PET is the short half-lives of the radionuclides used in the development of PET radiotracers.
    [Show full text]
  • Radiosynthesis of [18F]Fluorophenyl- L-Amino Acids by Isotopic Exchange on Carbonyl-Activated Precursors
    Jül - 4347 Institute of Neuroscience and Medicine (INM) Nuclear Chemistry (INM-5) Radiosynthesis of [18F]fluorophenyl- L-amino acids by isotopic exchange on carbonyl-activated precursors J. Castillo Meleán Mitglied der Helmholtz-GemeinschaftMitglied Berichte des Forschungszentrums Jülich 4347 Radiosynthesis of [18F]fluorophenyl- L-amino acids by isotopic exchange on carbonyl-activated precursors J. Castillo Meleán Berichte des Forschungszentrums Jülich; 4347 ISSN 0944-2952 Institute of Neuroscience and Medicine (INM) Nuclear Chemistry (INM-5) Jül-4347 D 38 (Diss., Köln, Univ., 2011) Vollständig frei verfügbar im Internet auf dem Jülicher Open Access Server (JUWEL) unter http://www.fz-juelich.de/zb/juwel Zu beziehen durch: Forschungszentrum Jülich GmbH · Zentralbibliothek, Verlag D-52425 Jülich · Bundesrepublik Deutschland Z 02461 61-5220 · Telefax: 02461 61-6103 · e-mail: [email protected] KURZZUSAMMENFASSUNG Aromatische [18F]Fluoraminosäuren sind als vielversprechende Radiodiagnostika für die Positronen-Emissions-Tomographie entwickelt worden. Eine breitere Anwendung dieser radio- fluorierten Verbindungen ist jedoch aufgrund der bisher notwendigen aufwändigen Radiochemie eingeschränkt. In dieser Arbeit wurde eine vereinfachte, dreistufige Radiosynthese von 2-[18F]Fluor-L- phenylalanin (2-[18F]Fphe), 2-[18F]Fluor-L-tyrosin (2-[18F]Ftyr), 6-[18F]Fluor-L-m-tyrosin (6- [18F]Fmtyr) und 6-[18F]Fluor-L-DOPA (6-[18F]FDOPA) entwickelt. Dazu wurden entsprechende Vorläufer durch einen nukleophilen Isotopenaustausch 18F-fluoriert, die entweder durch Entfernen der aktivierenden Formylgruppe mit Rh(PPh3)3Cl oder durch deren Umwandlung mittels Baeyer-Villiger Oxidation und anschließend durch saure Hydrolyse in die entsprechenden aromatischen [18F]Fluoraminosäuren überführt wurden. Zwei effiziente synthetische Ansätze wurden für die Synthese von hoch funktionalisierten Fluor- benzaldehyden und -ketonen entwickelt, die als Vorläufer benutzt wurden.
    [Show full text]
  • Synthesis of Organofluorine Compounds and Allenylboronic Acids - Applications Including Fluorine-18 Labelling Denise N
    Denise N. Meyer Synthesis of Organofluorine Compounds and Allenylboronic Synthesis of Organofluorine Compounds and Allenylboronic Acids - Applications Including Fluorine-18 Labelling Applications Acids - Allenylboronic Synthesis of Organofluorine Compounds and Acids - Applications Including Fluorine-18 Labelling Denise N. Meyer Denise N. Meyer Raised in Lauterecken, South-West Germany, Denise studied chemistry at Johannes Gutenberg University Mainz where she obtained her Bachelor's and Master's degree. In 2017, she moved to Stockholm where she pursued her doctoral studies with Prof. Kálmán J. Szabó. ISBN 978-91-7911-490-9 Department of Organic Chemistry Doctoral Thesis in Organic Chemistry at Stockholm University, Sweden 2021 Synthesis of Organofluorine Compounds and Allenylboronic Acids - Applications Including Fluorine-18 Labelling Denise N. Meyer Academic dissertation for the Degree of Doctor of Philosophy in Organic Chemistry at Stockholm University to be publicly defended on Friday 4 June 2021 at 10.00 in Magnélisalen, Kemiska övningslaboratoriet, Svante Arrhenius väg 16 B. Abstract This work is focused on two areas: the chemistry of organofluorine and organoboron compounds. In the first chapter, a copper-catalysed synthesis of tri- and tetrasubstituted allenylboronic acids is presented. Extension of the same method leads to allenylboronic esters. The very reactive and moisture-sensitive allenylboronic acids are further applied to the reaction with aldehydes, ketones and imines to form homopropargyl alcohols and amines. In addition, an enantioselective reaction catalysed by a BINOL organocatalyst was developed to form tertiary alcohols with adjacent quaternary carbon stereocenters. The second chapter specialises in the functionalisation of 2,2-difluoro enol silyl ethers with electrophilic reagents under mild reaction conditions.
    [Show full text]
  • One-Step Radiosynthesis of the Mcts Imaging Agent [18F]FACH By
    www.nature.com/scientificreports OPEN One-step radiosynthesis of the MCTs imaging agent [18F]FACH by aliphatic 18F-labelling of a methylsulfonate precursor containing an unprotected carboxylic acid group Masoud Sadeghzadeh1,2, Rareş-Petru Moldovan1, Rodrigo Teodoro1, Peter Brust 1 & Barbara Wenzel1,2* Monocarboxylate transporters 1 and 4 (MCT1 and MCT4) are involved in tumour development and progression. Their level of expression is particularly upregulated in glycolytic cancer cells and accordingly MCTs are considered as promising drug targets for treatment of a variety of human cancers. The non-invasive imaging of these transporters in cancer patients via positron emission tomography (PET) is regarded to be valuable for the monitoring of therapeutic efects of MCT inhibitors. Recently, we developed the frst 18F-radiolabelled MCT1/MCT4 inhibitor [18F]FACH and reported on a two-step one-pot radiosynthesis procedure. We herein describe now a unique one-step radiosynthesis of this radiotracer which is based on the approach of using a methylsulfonate (mesylate) precursor bearing an unprotected carboxylic acid function. With the new procedure unexpected high radiochemical yields of 43 ± 8% at the end of the radiosynthesis could be obtained in a strongly reduced total synthesis time. Moreover, the radiosynthesis was successfully transferred to a TRACERlab FX2 N synthesis module ready for future preclinical applications of [18F]FACH. Metabolic reprogramming is one of the two emerging hallmarks of cancer postulated by Hanahan and Weinberg in 20111. First observed by Warburg2, tumour cells primarily produce energy via switching from mitochondrial oxidative phosphorylation (MOP) to aerobic glycolysis even in the presence of oxygen3,4. Aerobic glycolysis is less energy efcient than MOP, but it appears to confer advantages for rapidly proliferating cells through the formation of metabolites like e.g.
    [Show full text]
  • Design, Radiosynthesis and Preliminary Biological Evaluation In
    International Journal of Molecular Sciences Article Design, Radiosynthesis and Preliminary Biological Evaluation 18 in Mice of a Brain-Penetrant F-Labelled σ2 Receptor Ligand Rare¸s-PetruMoldovan 1,* , Daniel Gündel 1 , Rodrigo Teodoro 1,2 , Friedrich-Alexander Ludwig 1 , Steffen Fischer 1, Magali Toussaint 1 , Dirk Schepmann 3, Bernhard Wünsch 3 , Peter Brust 1,4 and Winnie Deuther-Conrad 1,* 1 Department of Neuroradiopharmaceuticals, Research Site Leipzig, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Permoserstraße 15, 04318 Leipzig, Germany; [email protected] (D.G.); [email protected] (R.T.); [email protected] (F.-A.L.); s.fi[email protected] (S.F.); [email protected] (M.T.); [email protected] (P.B.) 2 Life Molecular Imaging GmbH, Tegeler Str. 6-7, 13353 Berlin, Germany 3 Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster (WWU), Corrensstraße 48, 48149 Münster, Germany; [email protected] (D.S.); [email protected] (B.W.) 4 The Lübeck Institute of Experimental Dermatology, University Medical Center Schleswig-Holstein, Ratzeburger Allee 160, 23562 Lübeck, Germany * Correspondence: [email protected] (R.-P.M.); [email protected] (W.D.-C.); Tel.: +49-341-234-179-4634 (R.-P.M.); +49-341-234-179-4613 (W.D.-C.) Abstract: The σ2 receptor (transmembrane protein 97), which is involved in cholesterol homeostasis, Citation: Moldovan, R.-P.; Gündel, is of high relevance for neoplastic processes. The upregulated expression of σ receptors in cancer D.; Teodoro, R.; Ludwig, F.-A.; 2 σ Fischer, S.; Toussaint, M.; Schepmann, cells and tissue in combination with the antiproliferative potency of 2 receptor ligands motivates the D.; Wünsch, B.; Brust, P.; research in the field of σ2 receptors for the diagnosis and therapy of different types of cancer.
    [Show full text]
  • Using Remote Labs.Indd
    Javier García Zubía and Gustavo R. Alves (eds.) Using Remote Labs in Education Two Little Ducks in Remote Experimentation Prize for Best Research UD – Grupo Santander DeustoDigital Using Remote Labs in Education Two Little Ducks in Remote Experimentation © University of Deusto - ISBN 978-84-9830-398-8 Using Remote Labs in Education Two Little Ducks in Remote Experimentation Javier García Zubía and Gustavo R. Alves (eds.) Juan Vélez S.J. Diego Gracia Carlos M.ª Romeo Javier Gafo S.J. Marciano Vidal José C. Bermejo 2011 University of Deusto Bilbao © University of Deusto - ISBN 978-84-9830-398-8 Engineering, no. 8 Edition revised by Anselmo del Moral Bueno Any form of reproduction, distribution, public communi- cation or transformation of the work can only be performed following authorisation by its owners, unless legally es- tablished otherwise. If you wish to photocopy or scan any part of this work please contact CEDRO (Centro Español de Derechos Reprográfi cos / Spanish Copyrights Centre) at www.cedro.org. © University of Deusto P.O. box 1 - 48080 Bilbao e-mail: [email protected] ISBN: 978-84-9830-398-8 Legal Deposit: BI - 3.409-2011 Impreso en España/Printed in Spain © University of Deusto - ISBN 978-84-9830-398-8 Contents Preface, Susan M. Zvacek . 11 Introduction, Javier García Zubía, Gustavo R. Alves . 17 SECTION 1 Pioneers Chapter 1. Second Best to Being There: An Historical Perspective, Molly H. Shor, Carisa Bohus, Burçin Atkan . 27 Chapter 2. Engineering Controls Labs Operated Remotely, Jim Henry, Murat Ozkaya . 53 SECTION 2 iLabs around the Globe Chapter 3.
    [Show full text]
  • [18F]FPEB and Preliminary PET Imaging in a Mouse Model of Alzheimer’S Disease
    molecules Communication Revisiting the Radiosynthesis of [18F]FPEB and Preliminary PET Imaging in a Mouse Model of Alzheimer’s Disease Cassis Varlow 1,2 , Emily Murrell 1, Jason P. Holland 3,4 , Alina Kassenbrock 3, Whitney Shannon 1,5, Steven H. Liang 3, Neil Vasdev 1,3,6,* and Nickeisha A. Stephenson 1,3,7,* 1 Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada; [email protected] (C.V.); [email protected] (E.M.); [email protected] (W.S.) 2 Institute of Medical Science, University of Toronto, Toronto, ON M5S1A8, Canada 3 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital & Department of Radiology, Harvard Medical School, Boston, MA 02114, USA; [email protected] (J.P.H.); [email protected] (A.K.); [email protected] (S.H.L.) 4 Department of Chemistry, University of Zurich, 8057 Zurich, Switzerland 5 Department of Chemistry, University of Saskatchewan, Saskatoon, SK S7N OX2, Canada 6 Department of Psychiatry, University of Toronto, Toronto, ON M5T-1R8, Canada 7 Department of Chemistry, The University of West Indies at Mona, Kingston 7, Jamaica * Correspondence: [email protected] (N.V.); [email protected] (N.A.S.); Tel.: +416-535-8501 (ext. 30988) (N.V.); +1-876-927-1910 (N.A.S.) Academic Editor: Svend Borup Jensen Received: 30 January 2020; Accepted: 20 February 2020; Published: 22 February 2020 Abstract: [18F]FPEB is a positron emission tomography (PET) radiopharmaceutical used for imaging the abundance and distribution of mGluR5 in the central nervous system (CNS).
    [Show full text]
  • Novel Late-Stage Radiosynthesis of 5-[18F]-Trifluoromethyl-1,2,4
    www.nature.com/scientificreports OPEN Novel late‑stage radiosynthesis of 5 ‑[1 8F] ‑tr if uorome thy l‑1 ,2, 4‑oxadiazole (TFMO) containing molecules for PET imaging Nashaat Turkman1,2*, Daxing Liu1,2 & Isabella Pirola1,2 Small molecules that contain the (TFMO) moiety were reported to specifcally inhibit the class‑IIa histone deacetylases (HDACs), an important target in cancer and the disorders of the central nervous system (CNS). However, radiolabeling methods to incorporate the [18F]fuoride into the TFMO moiety are lacking. Herein, we report a novel late‑stage incorporation of [18F]fuoride into the TFMO moiety in a single radiochemical step. In this approach the bromodifuoromethyl‑1,2,4‑oxadiazole was converted into [18F]TFMO via no‑carrier‑added bromine‑[18F]fuoride exchange in a single step, thus producing the PET tracers with acceptable radiochemical yield (3–5%), high radiochemical purity (> 98%) and moderate molar activity of 0.33–0.49 GBq/umol (8.9–13.4 mCi/umol). We validated the utility of the novel radiochemical design by the radiosynthesis of [18F]TMP195, which is a known TFMO containing potent inhibitor of class‑IIa HDACs. Te human histone deacetylases (HDACs) form a large family of 18 members and are catogerized into four classes (I–IV)1,2. Te class-IIa HDACs is a sub family comprised of four enzymes: HDAC-4, HDAC-5, HDAC-7 and HDAC-93–5. Tere is mounting evidence on a key role for the class-IIa HDACs in various cancers 6–11 and in the disorders of the central nervous system (CNS)12–16 including memory and cognitive impairment, dementia and behavioral changes among others17–25.
    [Show full text]